The randomized controlled trial (NAVKIDS2) of a patient navigator program created for children with chronic kidney disease

Germaine Wong(Children's Hospital at Westmead), Carmel M. Hawley(Translational Research Institute), Luke Macauley(Kidney Health Australia), Kylie‐Ann Mallitt(The University of Sydney), Deirdré Hahn(Children's Hospital at Westmead), Siah Kim, Donna Reidlinger(Translational Research Institute), Jonathan C. Craig(Flinders University), David W. Johnson(Hennepin County), Hugh J. McCarthy(University of Bristol), Shilpanjali Jesudason(South Australia Pathology), Anna Francis(Children's Health Queensland Hospital and Health Service), Kirsten Howard(The University of Sydney), Amélie Bernier-Jean(Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal), Martin Howell(UNSW Sydney), Anita van Zwieten(The University of Sydney), Julie Varghese(The University of Queensland), Martha Aquino(The University of Queensland), Rabia Khalid(The University of Sydney), Fiona Mackie(Sydney Children's Hospital), Chandana Guha(Children's Hospital at Westmead), Nicholas Larkins(The University of Western Australia), Patrina Caldwell(The University of Sydney), Reginald Woodleigh(Prostate Cancer Foundation of Australia), Sean Kennedy(UNSW Sydney), Stephen Alexander(The University of Sydney), Allison Jaure(The University of Sydney), Armando Teixeira-Pinto(The University of Sydney), Amanda Walker(Murdoch Children's Research Institute), Elizabeth G. Ryan(The University of Queensland), Simon Carter(Royal Children's Hospital), Steve McTaggart(Children’s Health Queensland Hospital and Health Service), Charani Kiriwandeniya(The University of Queensland)
Kidney International
July 1, 2024
Cited by 4


Related Papers